Your Canadian peptide store can be fully licensed, shipping on schedule, and still lose card processing on a Tuesday morning. No warning call. Just a frozen balance and a notice citing “risk appetite.”
That happens because peptide sellers almost always get approved through the wrong channel. A retail aggregator onboards you in minutes, skips real underwriting, then catches the product category weeks later during a routine review.
To get a peptide merchant account in Canada that actually survives, you need underwriting that understood your product on day one. Here is what that process looks like, what Canadian acquirers check, and what it costs.
Why Canadian Acquirers Flag Peptide Sellers
Canada does not have a single rule that bans peptide payments. The hesitation comes from a stack of overlapping concerns that underwriters evaluate together.
Most peptides sold online are not approved for human use in Canada. That alone places the merchant in a regulatory gray zone that acquirers treat as unresolved liability. Add the commercial pattern and the picture gets worse.
- Average order values run high, often several hundred dollars per shipment
- Repeat and subscription billing creates ongoing dispute exposure
- Every sale is card-not-present, which carries higher fraud rates
- Customers frequently sit outside Canada, adding cross-border decline risk
- Website claims about dosing or results can trigger card network compliance reviews
The peptide sector is also growing fast enough to attract attention. According to Mordor Intelligence, the peptide therapeutics market is projected to reach USD 70.20 billion by 2031, at a 7.16% CAGR. Acquirers see that growth curve and tighten underwriting rather than loosen it.
Where Peptides Sit Under Canadian Rules
This is the part most merchants skip, and it decides the application outcome.
Health Canada Controls What You Can Legally Sell
Peptides intended for human use fall under the Food and Drugs Act. Many of them, including GLP-1 compounds, sit on the Prescription Drug List. Selling those without authorization is a regulatory offense, not a gray area.
Compounds marketed as natural health products need an NPN from Health Canada. Most research peptides do not qualify and never will.
Research Use Only Is a Label, Not a Shield
Underwriters read your site, not your disclaimer. If your product pages carry a research-use notice but your FAQ discusses injection protocols, the disclaimer fails.
The distinction between a research peptide and a cosmetic peptide determines which MCC you qualify for and which acquirers will even look at your file. Sort that out before you apply, because you cannot argue it later.
Your Website Is Part of the Application File
Compliance teams screenshot your checkout, your shipping policy, and your product claims. Before/after imagery, testimonials describing results, and “for athletes” positioning all read as human-use marketing.
Clean that language first. One unreviewed landing page can sink an otherwise solid application.
Domestic Canadian Account or Offshore Acquiring
Canadian domestic acquirers like the major bank-owned processors rarely board peptide merchants. Their underwriting policies exclude unapproved health compounds outright, regardless of your revenue.
That leaves two realistic routes. A domestic account through a specialist acquirer with a Canadian entity, or offshore acquiring through an EU or UK banking relationship with multi-currency settlement.
Domestic gives you CAD settlement, Interac acceptance, and better local approval rates. Offshore gives you broader risk tolerance, faster onboarding, and easier handling of international customers. The tradeoffs between domestic and offshore peptide merchant accounts come down to where your buyers are and how much reserve you can absorb.
Many Canadian peptide businesses end up running both. Domestic for Canadian volume, offshore for everything else.
What Underwriters Will Ask For
Incomplete files cause more delays than risk concerns do. Assemble this before you submit anything.
Corporate documents
- Certificate of incorporation, federal or provincial
- CRA business number and GST/HST registration
- Articles of incorporation and shareholder register
- Government ID and proof of address for every director and beneficial owner above 25%
Financial records
- Three to six months of business bank statements
- Processing history with volume, refund rate, and chargeback ratio
- Any prior account closure letters, disclosed voluntarily
Operational documents
- Supplier agreements and certificates of analysis
- Product list with intended use for each SKU
- Refund, cancellation, and shipping policies published live on the site
- Projected monthly volume and average ticket size
Disclose previous terminations yourself. Underwriters check the MATCH list anyway, and a disclosed closure is survivable. A hidden one ends the application.
How to Get a Peptide Merchant Account in Canada Without Wasting Three Months
Step 1: Fix Classification and Site Copy First
Decide what you sell and align every page to it. Research-only products need research-only language everywhere, including meta descriptions and ad copy.
Remove dosage charts, protocol guides, and health outcome claims. Keep your certificates of analysis visible, because they support legitimacy without implying human use.
Step 2: Build the Corporate and Banking Stack
Incorporate properly and open a business bank account in the same legal name. Personal accounts and mismatched entity names are automatic declines.
If you plan to settle in CAD, you need a Canadian entity. If you are selling mainly into the US or Europe, discuss multi-currency settlement before you pick your structure.
Step 3: Apply Through a Specialist, Not an Aggregator
The core requirements for a peptide merchant account stay consistent across markets, but Canadian underwriting adds a Health Canada layer on top.
Work with a provider that has live peptide merchants in its portfolio. Ask directly how many peptide accounts they currently support and what their average approval timeline looks like. Vague answers mean they are shopping your file around.
Step 4: Prepare for the Underwriting Conversation
Expect follow-up questions on supplier sourcing, customer geography, and dispute handling. Answer with specifics and documentation.
This is also where you negotiate. Reserve percentage, release schedule, and settlement frequency are all discussable before signing, and almost impossible to change afterward.
Fees, Reserves, and Settlement Terms to Expect
No peptide business will get a peptide merchant account in Canada at retail card rates. Price the risk into your margins from the start.
Processing rates typically land between 4% and 8%, depending on volume, geography, and chargeback history. Expect a setup fee, monthly gateway charges, and per-transaction fees on top.
Rolling reserves are standard. Most new peptide accounts start at 5% to 10% of processed volume, held for 90 to 180 days. On $100,000 in monthly volume at a 10% reserve, that is $10,000 per month locked up until the first release cycle begins.
Plan cash flow around that. Merchants who ignore the reserve timeline hit a liquidity wall in month two, not month six.
Settlement is usually weekly or bi-weekly at first. Clean processing for six months is the normal threshold for negotiating daily settlement and a lower reserve.
Payment Methods Canadian Buyers Actually Use
Card acceptance alone leaves money on the table in Canada.
Interac e-Transfer is widely used for higher-value purchases and carries no chargeback mechanism, which makes it attractive for peptide sellers. Many specialist providers can integrate it alongside your card rails.
Interac Debit covers a large share of domestic checkout traffic. Visa and Mastercard credit remain essential for US and international buyers.
Crypto acceptance is worth considering as a secondary rail, not a primary one. It removes dispute risk but introduces volatility and its own compliance obligations.
Running two or three rails protects you. If your card account goes under review, the business keeps collecting revenue.
Keeping the Account After Approval
Approval is the easy half. Retention depends on your dispute ratio staying below the thresholds that trigger Visa and Mastercard monitoring programs.
Set your billing descriptor to match your store name exactly. A descriptor showing a holding company name generates confusion disputes that are entirely avoidable. Test it with a live transaction after onboarding.
Send an order confirmation immediately and a shipping notification with tracking. For subscriptions, send a renewal reminder three to five days before each charge, with a working cancellation link inside it. Those reminders also keep you aligned with CASL consent rules for commercial email.
Enable AVS matching, CVV verification, velocity limits, and 3D Secure on higher-value orders. Chargeback alert services from Ethoca and Verifi let you refund a dispute before it counts against your ratio. Understanding how chargebacks in the peptide sector typically originate helps you target controls instead of guessing.
Store customer data in line with PIPEDA, and keep KYC records, delivery confirmations, and communication logs organized. That evidence file is what wins representments.
Red Flags That Get Applications Declined
- Mismatched entity names across incorporation, bank account, and website
- Human-use claims sitting alongside research-only disclaimers
- Undisclosed prior terminations or MATCH list entries
- No published refund policy or unreachable customer support
- Applying to five aggregators first and collecting rejections
Final Word
Businesses that get a peptide merchant account in Canada and keep it are not the ones with the cleanest product line. They are the ones who treated underwriting as a preparation problem instead of a paperwork step.
Classify your products honestly. Clean your site copy. Build the entity and banking stack correctly. Then apply once, through a provider who already understands this category.
At EMS Global, we help peptide merchants structure Canadian and cross-border payment setups that hold up under review. If you are starting fresh or recovering from a closure, talk to our team about the right structure for your volume and customer base.
FAQs
How long does it take to get a peptide merchant account in Canada?
With complete documentation and clean site copy, approval usually takes two to four weeks. Missing documents, unclear product classification, or undisclosed closures can push it past six weeks.
Can I use Stripe or Square for peptide sales in Canada?
Not reliably. Both prohibit unapproved health compounds in their acceptable use policies. Accounts often process for a few weeks before being frozen, with funds held for 90 to 180 days.
Do I need a Canadian company to apply?
For a domestic account with CAD settlement, yes. Offshore acquiring routes accept foreign entities, though they usually require a corresponding business bank account in a compatible jurisdiction.
What rolling reserve should I expect?
Most new peptide accounts start at 5% to 10% held for 90 to 180 days. Six months of clean processing is the usual point at which providers will discuss reducing it.
Will Health Canada approval improve my chances?
An NPN or drug identification number removes the biggest underwriting objection and opens access to far more acquirers. Without one, you need tight research-use positioning throughout your site.
